Popular search terms:
Search Results
13 results found-
CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.cslseqirus.us/expertise -
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.cslseqirus.us/our-company/leadership -
CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.cslseqirus.us/our-company -
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.cslseqirus.us/our-company/leadership/gregg-sylvester -
Nephrology and transplant Therapeutic Areas (which expertise to provide the Focus
https://www.cslseqirus.us/-/media/shared/documents/annual-report/csl-annual-report-2024.pdf -
Renewal reaffirms longstanding, public-private partnership between Seqirus and the Biomedical Advanced Research and Development Authority (BARDA)
https://www.cslseqirus.us/news/seqirus-and-us-gov-renew-multi-year-agreement-for-influenza-pandemic-preparedness-and-response -
Seqirus will develop and evaluate two influenza A(H2Nx) virus vaccine candidates in support of U.S. government pandemic preparedness objectives
https://www.cslseqirus.us/news/seqirus-awarded-us-government-contract-for-two-influenza-vaccines -
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
https://www.cslseqirus.us/news/the-university-of-queensland-cepi-and-csl-partner-on-covid-19-vaccine-candidate -
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.cslseqirus.us/news/covid19-update -
Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season
https://www.cslseqirus.us/news/seqirus-is-first-to-market-with-shipment-of-seasonal-influenza-vaccines-for-2016-2017-season